# Chunghwa Chemical Synthesis & Biotech Co., Ltd – FDA Inspection, Nov 9, 2018

Source: https://www.keypedia.com/records/fda_inspections/chunghwa-chemical-synthesis-biotech-co-ltd/5912c1cf-d6c4-457c-ab1e-f4aba74580f7
Source feed: FDA_Inspections

> FDA inspection 1073483 of Chunghwa Chemical Synthesis & Biotech Co., Ltd, November 09, 2018. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1073483
- Company Name: Chunghwa Chemical Synthesis & Biotech Co., Ltd
- Inspection Date: 2018-11-09
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1241802 - 2024-04-12
- FDA Inspection 1192138 - 2022-11-18
- FDA Inspection 1151870 - 2021-06-21
- FDA Inspection 1013091 - 2017-03-29
- FDA Inspection 881707 - 2014-05-20

## Related Officers

- [Company Rep](https://www.keypedia.com/people/michael-l-casner/a0f35f37-4795-4edf-a9f6-a447d64c0fd4)

Company: https://www.keypedia.com/companies/chunghwa-chemical-synthesis-biotech-co-ltd/4c8ab291-0275-4884-960a-f5b3bc604eff

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
